Amgen Inc financial data

Symbol
AMGN on Nasdaq
Location
One Amgen Center Drive, Thousand Oaks, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 125 % -11%
Quick Ratio 30.2 % -28.2%
Return On Equity 96.2 % +40.4%
Return On Assets 7.8 % +71.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 538M shares +0.18%
Common Stock, Shares, Outstanding 539M shares +0.19%
Entity Public Float 168B USD +41.4%
Weighted Average Number of Shares Outstanding, Basic 538M shares +0.19%
Weighted Average Number of Shares Outstanding, Diluted 542M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 36B USD +10.6%
Costs and Expenses 27.3B USD +3.74%
Operating Income (Loss) 8.67B USD +39.5%
Nonoperating Income (Expense) 2.42B USD +43.3%
Income Tax Expense (Benefit) 1.24B USD +176%
Net Income (Loss) Attributable to Parent 7.01B USD +65.6%
Earnings Per Share, Basic 13 USD/shares +65.4%
Earnings Per Share, Diluted 12 USD/shares +65.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 9.45B USD +4.82%
Accounts Receivable, after Allowance for Credit Loss, Current 8.49B USD +16%
Inventory, Net 6.35B USD -13.8%
Other Assets, Current 3.6B USD +17.2%
Assets, Current 27.9B USD +4.18%
Property, Plant and Equipment, Net 7.22B USD +17.3%
Operating Lease, Right-of-Use Asset 557M USD -14.4%
Intangible Assets, Net (Excluding Goodwill) 23.1B USD -20%
Goodwill 18.7B USD +0.1%
Other Assets, Noncurrent 13.2B USD +27.3%
Assets 90.1B USD -0.82%
Accounts Payable, Current 2.84B USD +32.2%
Employee-related Liabilities, Current 1.33B USD -3.77%
Accrued Liabilities, Current 16.8B USD +14.9%
Liabilities, Current 21.8B USD +7.28%
Deferred Income Tax Liabilities, Net 1.46B USD -14.8%
Operating Lease, Liability, Noncurrent 673M USD -2.61%
Other Liabilities, Noncurrent 2.22B USD +1.09%
Common Stocks, Including Additional Paid in Capital 33.8B USD +1.34%
Accumulated Other Comprehensive Income (Loss), Net of Tax -422M USD -25.6%
Retained Earnings (Accumulated Deficit) -23.8B USD +6.78%
Stockholders' Equity Attributable to Parent 9.62B USD +27.8%
Liabilities and Equity 90.1B USD -0.82%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 1.39B USD +102%
Net Cash Provided by (Used in) Financing Activities -4.11B USD -140%
Net Cash Provided by (Used in) Investing Activities -447M USD -106%
Common Stock, Shares Authorized 2.75B shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -3.16B USD -156%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9.45B USD +4.82%
Deferred Tax Assets, Valuation Allowance 1.02B USD +6.48%
Deferred Tax Assets, Gross 6B USD +8.78%
Operating Lease, Liability 780M USD -3.7%
Payments to Acquire Property, Plant, and Equipment 411M USD +78.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6.92B USD +72.1%
Lessee, Operating Lease, Liability, to be Paid 941M USD -3.69%
Property, Plant and Equipment, Gross 16.9B USD +7.51%
Operating Lease, Liability, Current 107M USD -10.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two 129M USD +6.61%
Lessee, Operating Lease, Liability, to be Paid, Year One 110M USD -20.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 161M USD -3.59%
Lessee, Operating Lease, Liability, to be Paid, Year Three 112M USD +2.75%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 4.18B USD +4.29%
Lessee, Operating Lease, Liability, to be Paid, Year Four 91M USD -4.21%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 4.6B USD -2.56%
Depreciation, Depletion and Amortization 1.39B USD -0.86%
Deferred Tax Assets, Net of Valuation Allowance 4.98B USD +9.27%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%